PRMT7 antibody (N-Term)
Quick Overview for PRMT7 antibody (N-Term) (ABIN632137)
Target
See all PRMT7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- PRMT7 antibody was raised against the N terminal of PRMT7
-
Purification
- Affinity purified
-
Immunogen
- PRMT7 antibody was raised using the N terminal of PRMT7 corresponding to a region with amino acids MKIFCSRANPTTGSVEWLEEDEHYDYHQEIARSSYADMLHDKDRNVKYYQ
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PRMT7 Blocking Peptide, catalog no. 33R-6141, is also available for use as a blocking control in assays to test for specificity of this PRMT7 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PRMT7 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))
-
Alternative Name
- PRMT7
-
Background
- Arginine methylation is an apparently irreversible protein modification catalyzed by arginine methyltransferases, such as PMT7, using S-adenosylmethionine (AdoMet) as the methyl donor. Arginine methylation is implicated in signal transduction, RNA transport, and RNA splicing.
-
Molecular Weight
- 78 kDa (MW of target protein)
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Target
-